Evidence map›Paper›PMID 41261207›Full record

ReviewPlant foods for human nutrition (Dordrecht, Netherlands)2025

Isovitexin: A Promising Active Compound Found in Nature's Bounty.

Hao Cheng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hao ChengSchool of Pharmacy, North Sichuan Medical College, Nanchong, China. haocheng1996@126.com.ORCID http://orcid.org/0009-0001-7585-0507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isovitexin, a natural flavone C-glycosylated derivative, displays a wide range of biological activities and holds significant application potential. However, a comprehensive review summarizing the existing knowledge on isovitexin is currently lacking. This review aims to provide an extensive synthesis of current research on isovitexin to enhance scientific understanding and support future investigations. Relevant literature on isovitexin was collected and analyzed from several databases, including Scopus, PubMed, Google Scholar, and Web of Science. The current knowledge on isovitexin is summarized below, focusing on key aspects. First, isovitexin is widely distributed and can be separated from numerous plants, such as Colocasia esculenta, mung bean, and Lespedeza cuneata G. Don. Second, pharmacokinetic studies indicate that following oral administration, only a small portion of isovitexin is directly absorbed, while the majority is transferred to the intestine and metabolized by gut microbiota. Isovitexin demonstrates diverse biological activities, including immunomodulatory, antioxidant properties, anticancer activity, neuroprotection, regulation of bone homeostasis, and hepatoprotective effects. These activities are mediated through multiple mechanisms, including anti-inflammatory effects through inhibition of the Nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase pathways, antioxidant effects by suppression of myeloperoxidase activity and the scavenging of reactive oxygen species (ROS), and anticancer activity by promoting autophagy and apoptosis. In conclusion, isovitexin is a promising natural plant-derived compound with abundant sources and a broad spectrum of physiological activities.

Indexed as

ApigeninAnimalsAnti-Inflammatory AgentsAntioxidantsHumansImmunologic FactorsNeuroprotective AgentsPlant ExtractsAnti-Inflammatory AgentsAntioxidantsApigeninImmunologic FactorsisovitexinNeuroprotective AgentsPlant ExtractsBiological activitiesFlavonoid C-glycosidesIsovitexinPhytochemical

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.